|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.32 USD | -45.21% |
|
-44.79% | -95.82% |
| 21/05 | FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD | CI |
| 08/05 | Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
On January 5, 2023, Jeff Conroy provided Cingulate Inc. with notice of his resignation from the Board of Directors.
| 1st Jan change | Capi. | |
|---|---|---|
| -95.82% | 22.11L | |
| +19.41% | 4.55TCr | |
| +38.65% | 3.94TCr | |
| -8.62% | 3.85TCr | |
| +26.95% | 3.07TCr | |
| -13.50% | 2.6TCr | |
| +10.74% | 2.59TCr | |
| +44.87% | 1.41TCr | |
| +34.36% | 1.27TCr | |
| -7.14% | 1.13TCr |
CINGULATE INC. 
